Free Trial

Silverback Therapeutics (SBTX) Insider Trading & Ownership

Silverback Therapeutics logo
$11.18 -0.14 (-1.24%)
(As of 12/20/2024 ET)

Silverback Therapeutics (NASDAQ:SBTX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
34.40%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
$18,224.50
Number Of
Insiders Selling
(Last 3 Years)
0
Get SBTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Silverback Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SBTX Insider Buying and Selling by Quarter

Silverback Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/3/2022Jonathan D RootDirectorBuy350$52.07$18,224.50  
(Data available from 1/1/2013 forward)

SBTX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Silverback Therapeutics includes Jonathan D Root. Learn more on insiders at SBTX.

34.40% of Silverback Therapeutics stock is owned by insiders. Learn more on SBTX's insider holdings.

Silverback Therapeutics Key Executives

  • Dr. Peter A. Thompson FACP (Age 62)
    M.D., Co-Founder & Chairman of Directors
    Compensation: $5.12k
  • Mr. Jeffrey C. Pepe J.D.
    Ph.D., Interim CEO, Gen. Counsel & Corp. Sec.
  • Mr. Russ Hawkinson (Age 63)
    Sr. VP of Fin., Interim CFO, Principal Financial Officer & Principal Accounting Officer
  • Mr. Miguel Arcinas M.B.A.
    VP of Corp. Devel. & Investor Relations
  • Jen More
    Director of HR
  • Ms. Sue Hamke
    Sr. VP of Clinical Operations
  • Mr. Dario Gobunquin CPA
    Sr. Director of Accounting & Controller


This page (NASDAQ:SBTX) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners